This is the molecular strategy of actively reducing the expression of genes that promote cellular senescence, a state of irreversible growth arrest and dysfunctional aging. Downregulating these specific genes helps prevent the accumulation of senescent cells, which secrete harmful pro-inflammatory factors, thereby preserving tissue function and reducing the systemic inflammatory load associated with aging. This is a direct intervention on a primary driver of biological aging.
Origin
The term combines “senescence,” derived from the Latin senescere meaning “to grow old,” with the genetic concept of “downregulation,” which means decreasing the rate of gene transcription. The concept is central to the field of senolytics and longevity research, where the goal is to target and mitigate the negative impact of aging cells.
Mechanism
Downregulation is achieved by modulating transcription factors or epigenetic mechanisms that control the promoter regions of senescence-associated genes, such as p16INK4a and p21. Specific molecules or hormonal signals can be introduced to bind to inhibitory elements, reducing the transcription of these pro-senescence factors. The resulting effect is a decrease in the number of senescent cells and a subsequent reduction in the detrimental Senescence-Associated Secretory Phenotype (SASP) throughout the tissue microenvironment.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.